Select a Sector or Industry
Biotechnology Stock Rankings
-
Accounts Payable
-
Accounts Receivable
-
Accruals
Pro
-
Altman Z-Score
Pro
-
Asset Utilization
-
Beneish M-Score
Pro
-
Book Value
-
Book Value per Share
-
Capital Expenditures
-
Cash Conversion Cycle
Pro
-
Cash Div. Payout Ratio TTM
Pro
-
Cash Financing
-
Cash Financing TTM
-
Cash Investing
-
Cash Investing TTM
-
Cash Operations
-
Cash Operations TTM
-
Cash and Equivalents
-
Cash and ST Investments
-
Current Ratio
-
Days Inventory Outstanding
Pro
-
Days Payable Outstanding
Pro
-
Days Sales Outstanding
Pro
-
Debt to Equity Ratio
-
Dividend Yield
-
EBITDA Margin TTM
Pro
-
EBITDA TTM
Pro
-
EV / EBIT
Pro
-
EV / EBITDA
Pro
-
EV / Free Cash Flow
Pro
-
EV / Revenues
Pro
-
Earnings Per Share
-
Earnings Per Share Growth
-
Earnings Per Share TTM
-
Earnings Yield
-
Effective Tax Rate TTM
Pro
-
Enterprise Value
-
Expenses
-
Expenses TTM
-
Free Cash Flow
-
Free Cash Flow TTM
-
Free Cash Flow Yield
Pro
-
Fundamental Score
Pro
-
Gross Profit Margin
-
Gross Profit TTM
-
Income from Cont. Ops
Pro
-
Interest Expense
-
Interest Income
-
Inventories
-
KZ Index
Pro
-
Liabilities
-
Long Term Debt
-
Market Cap
-
Net Income
-
Net Income TTM
-
Net PP&E
-
Operating Earnings Yield
Pro
-
Operating Margin TTM
Pro
-
Operating PE Ratio
Pro
-
Other Comprehensive Income
Pro
-
PE 10
Pro
-
PE Ratio
-
PE Value
Pro
-
PEG Ratio
-
PS Value
Pro
-
Payout Ratio TTM
Pro
-
Price
-
Price / Book Value
-
Price / Sales Ratio
-
Price / Tangible Book Value
Pro
-
Profit Margin
-
R&D Expense
-
Receivables Turnover
-
Retained Earnings
-
Retained Earnings Growth
-
Return on Assets
-
Return on Equity
-
Return on Invested Capital
Pro
-
Revenue Growth
-
Revenue Per Share TTM
-
Revenues
-
Revenues TTM
-
SG&A Expense
-
Shareholders Equity
-
Shares Outstanding
-
Stock Buybacks
-
Tangible Book Value
Pro
-
Tangible Book Value Per Share
Pro
-
Tangible Common Equity Ratio
Pro
-
Times Interest Earned TTM
Pro
-
Total Assets
-
Valuation (Historical Mult.)
Pro
-
Valuation Percentage
Pro
-
Value Score
Pro
Select from over 70 financial rankings
Or choose from these popular rankings:
Market Cap
View All
1
AMGN
Amgen
53.14B
2
GILD
Gilead Sciences
36.90B
3
BIIB
Biogen Idec
30.25B
4
CELG
Celgene Corporation
28.67B
5
ALXN
Alexion Pharmaceuticals
16.29B
PE Ratio
View All
1
GEVA
Synageva BioPharma
0.4015
2
CBP
China Botanic Pharmaceutical
0.8629
3
DNDN
Dendreon Corporation
2.828
4
PDLI
PDL BioPharma
5.311
5
MNTA
Momenta Pharmaceuticals
5.953
Dividend Yield
View All
1
PDLI
PDL BioPharma
9.20%
2
HSKA
Heska Corporation
3.30%
3
RELV
Reliv' International
2.90%
4
AMGN
Amgen
2.10%
5
SHPGY
Shire
0.90%
Return on Equity
View All
1
ENMD
EntreMed
664.2%
2
EXEL
Exelixis
510.4%
3
QCOR
Questcor Pharmaceuticals
59.89%
4
NBIX
Neurocrine Biosciences
54.48%
5
JAZZ
Jazz Pharmaceuticals
51.20%
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
Market Cap
View All| 1 | AMGN | Amgen | 53.14B |
|---|---|---|---|
| 2 | GILD | Gilead Sciences | 36.90B |
| 3 | BIIB | Biogen Idec | 30.25B |
| 4 | CELG | Celgene Corporation | 28.67B |
| 5 | ALXN | Alexion Pharmaceuticals | 16.29B |
PE Ratio
View All| 1 | GEVA | Synageva BioPharma | 0.4015 |
|---|---|---|---|
| 2 | CBP | China Botanic Pharmaceutical | 0.8629 |
| 3 | DNDN | Dendreon Corporation | 2.828 |
| 4 | PDLI | PDL BioPharma | 5.311 |
| 5 | MNTA | Momenta Pharmaceuticals | 5.953 |
Dividend Yield
View All| 1 | PDLI | PDL BioPharma | 9.20% |
|---|---|---|---|
| 2 | HSKA | Heska Corporation | 3.30% |
| 3 | RELV | Reliv' International | 2.90% |
| 4 | AMGN | Amgen | 2.10% |
| 5 | SHPGY | Shire | 0.90% |
Return on Equity
View All| 1 | ENMD | EntreMed | 664.2% |
|---|---|---|---|
| 2 | EXEL | Exelixis | 510.4% |
| 3 | QCOR | Questcor Pharmaceuticals | 59.89% |
| 4 | NBIX | Neurocrine Biosciences | 54.48% |
| 5 | JAZZ | Jazz Pharmaceuticals | 51.20% |